Vanga v. Gluckman CA2/8

CourtCalifornia Court of Appeal
DecidedFebruary 1, 2023
DocketB304687
StatusUnpublished

This text of Vanga v. Gluckman CA2/8 (Vanga v. Gluckman CA2/8) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vanga v. Gluckman CA2/8, (Cal. Ct. App. 2023).

Opinion

Filed 2/1/23 Vanga v. Gluckman CA2/8 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION EIGHT

RODERICK EARL VANGA, B304687

Plaintiff and Appellant, Los Angeles County Super. Ct. No. BC702702 v.

RICHARD S. GLUCKMAN et al.,

Defendants and Respondents.

APPEAL from a judgment of the Superior Court of Los Angeles County, Gregory W. Alarcon, Judge. Conditionally reversed and remanded with directions. Steven J. Cooper for Plaintiff and Appellant. Cole Pedroza, Kenneth R. Pedroza, Matthew S. Levinson; Reback, McAndrews & Blessey, Raymond L. Blessey and Tracy D. Hughes for Defendants and Respondents. __________________________ INTRODUCTION

When plaintiff and appellant Roderick Earl Vanga, a federal prisoner, started to lose his eyesight, the prison called in a neurologist, Dr. Richard S. Gluckman, to examine him. But Vanga’s treatment was delayed, and he ultimately went legally blind in both eyes. Vanga, acting in propria persona, sued defendants and respondents Dr. Gluckman and Richard S. Gluckman, M.D., Inc. (collectively Gluckman) for professional negligence, contending that Gluckman had unreasonably delayed providing a diagnosis and treatment plan to the prison, and, but for the delay, Vanga wouldn’t have lost his sight. Vanga, who was not only incarcerated and blind but also indigent, asked the trial court to appoint counsel to represent him. The court denied the request.1 When Gluckman moved for summary judgment, Vanga moved for appointment of a medical expert. The court denied that request as well, holding that Vanga had not made a sufficient showing of necessity. The court held that Vanga’s “claims that he is in custody, visually disabled, and indigent are not a sufficient basis alone for this court to exercise its discretion to appoint an expert at public expense . . . [and] there is no evidence that this action involves an extremely complicated area of medicine which would warrant an increased state interest for a court appointed expert.” The court then granted summary judgment for Gluckman, holding that Vanga had not rebutted Gluckman’s declaration that the doctor’s actions fell within the standard of care because Vanga had not provided contrary expert testimony.

1 Vanga has since obtained counsel.

2 On appeal, Vanga argues that the court’s refusal to appoint a medical expert deprived him of meaningful access to the courts.2 We agree. We therefore conditionally reverse the judgment and remand with directions.

BACKGROUND

1. Factual Background Vanga was an inmate at the Federal Correctional Institute (FCI) Terminal Island when he began suffering vision loss. Gluckman, a board-certified neurologist, was brought in to examine him. Gluckman examined Vanga’s right eye on January 28, 2016. Gluckman diagnosed Vanga with optic neuritis and prescribed intravenous injections of Solu-Medrol, a drug whose common name is Methylprednisolone, an anti-inflammatory steroid, for four or five days and that he begin taking Aubagio, whose common name is Teriflunomide, a medication used to treat multiple sclerosis. Gluckman declared that he provided his diagnoses, suggestions, and other findings regarding the examination to the medical office at FCI Terminal Island on February 1, 2016. But Venga’s complaint alleges that the treatment plan was not delivered until February 16, 2016. In any event, treatment began on March 24, 2016. Gluckman evaluated Vanga again on August 25, 2016, this time focusing on the left eye. Gluckman again diagnosed Vanga with optic neuritis. This time, he prescribed six months of intravenous injections of Solu-Medrol for two consecutive days

2 Because this issue is dispositive, we do not address Vanga’s additional claims of error.

3 per month. Gluckman declared that he provided his diagnoses, suggestions, and other findings regarding the examination to the medical office at FCI Terminal Island on August 27, 2016. Venga, however, alleges that the treatment plan was not delivered to the prison until November 15, 2016. Treatment began on November 16, 2016. Vanga is now legally blind in both eyes. 2. Complaint Vanga filed the operative verified complaint on April 17, 2018, asserting professional negligence. He alleged that Gluckman delayed delivery of the two treatment plans to the prison for an unreasonable length of time and that these delays caused him to suffer permanent vision loss. By his action, Vanga sought to recover general damages, compensatory damages, and costs of suit. 3. Summary Judgment Proceedings Gluckman moved for summary judgment on the ground that the care and treatment provided to Vanga was within the applicable standard of care, and no act or omission by Gluckman caused or contributed to Vanga’s injuries. Gluckman also argued that Vanga’s claims were barred by the statute of limitations. Vanga opposed the motion, arguing that Gluckman’s actions were not within the applicable standard of care. Vanga filed a concurrent request for appointment of a medical expert. The court heard the motion on July 23, 2019. Vanga appeared telephonically. The court took under submission both Gluckman’s motion for summary judgment and Vanga’s request for expert witnesses. Then, on August 13, 2019, the trial court issued a written order denying Vanga’s request for court-

4 appointed experts and granting the motion for summary judgment. 4. Judgment and Appeal Vanga filed a motion for reconsideration, which the court denied. The court signed and entered a judgment in favor of Gluckman on January 2, 2020. Vanga timely appeals.

DISCUSSION

Vanga contends the court’s refusal to appoint a medical expert to contest summary judgment deprived him of meaningful access to the courts. We agree. 1. Standard of Review We review the denial of Vanga’s motion for appointment of a medical expert for abuse of discretion. (Wantuch v. Davis (1995) 32 Cal.App.4th 786, 792–793 (Wantuch); People v. Garcia (2016) 5 Cal.App.5th 640, 655.) The standard of review of an order granting summary judgment is well established. “The purpose of the law of summary judgment is to provide courts with a mechanism to cut through the parties’ pleadings in order to determine whether, despite their allegations, trial is in fact necessary to resolve their dispute.” (Aguilar v. Atlantic Richfield Co. (2001) 25 Cal.4th 826, 843.) The moving party “bears the burden of persuasion that there is no triable issue of material fact and that he is entitled to judgment as a matter of law.” (Id. at p. 850; Code Civ. Proc., § 437c, subd. (c).) The pleadings determine the issues to be addressed by a summary judgment motion. (Nieto v. Blue Shield

5 of California Life & Health Ins. Co. (2010) 181 Cal.App.4th 60, 74.) On appeal from a summary judgment, we review the record de novo and independently determine whether triable issues of material fact exist. (Saelzler v. Advanced Group 400 (2001) 25 Cal.4th 763, 767; Guz v. Bechtel National, Inc. (2000) 24 Cal.4th 317, 334.) We resolve any evidentiary doubts or ambiguities in favor of the party opposing summary judgment. (Saelzler, at p. 768.) In performing an independent review of the granting of summary judgment, “we follow the traditional three-step analysis. ‘We first identify the issues framed by the pleadings, since it is these allegations to which the motion must respond. Secondly, we determine whether the moving party has established facts which negate the opponents’ claim and justify a judgment in the movant’s favor.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pink v. Slater
281 P.2d 272 (California Court of Appeal, 1955)
Corenevsky v. Superior Court
682 P.2d 360 (California Supreme Court, 1984)
People v. Watson
299 P.2d 243 (California Supreme Court, 1956)
La Ronda Collins v. Superior Court of Los Angeles County
74 Cal. App. 3d 47 (California Court of Appeal, 1977)
Nieto v. Blue Shield of California Life & Health Insurance
181 Cal. App. 4th 60 (California Court of Appeal, 2010)
Wantuch v. Davis
32 Cal. App. 4th 786 (California Court of Appeal, 1995)
Apollo v. Gyaami
167 Cal. App. 4th 1468 (California Court of Appeal, 2008)
Shamsian v. Atlantic Richfield Co.
132 Cal. Rptr. 2d 635 (California Court of Appeal, 2003)
Oakland Raiders v. National Football League
32 Cal. Rptr. 3d 266 (California Court of Appeal, 2005)
Aguilar v. Atlantic Richfield Co.
24 P.3d 493 (California Supreme Court, 2001)
Cassim v. Allstate Insurance
94 P.3d 513 (California Supreme Court, 2004)
Guz v. Bechtel National, Inc.
8 P.3d 1089 (California Supreme Court, 2000)
Saelzler v. Advanced Group 400
23 P.3d 1143 (California Supreme Court, 2001)
People v. Garcia
5 Cal. App. 5th 640 (California Court of Appeal, 2016)
Smith v. Ogbuehi
251 Cal. Rptr. 3d 185 (California Court of Appeals, 5th District, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Vanga v. Gluckman CA2/8, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vanga-v-gluckman-ca28-calctapp-2023.